Profusa, Inc. (PFSA) · Oct 9, 2026 · Auditor change

Profusa auditor change keeps material weaknesses in focus

Auditor change — material weaknesses had not been remediated as of June 30, 2026

Profusa changed auditors, but its new 8-K confirms unresolved financial-control weaknesses and an earlier going-concern warning remain central.

Profusa is a commercial-stage digital-health company developing injectable biosensors and AI-driven health-management platforms, but it remains financially and operationally fragile. The auditor transition is procedural, not a business advance. CBIZ was dismissed and Withum was engaged for the fiscal year ending December 31, 2026; the filing reports no accounting disagreements or reportable events tied to the change. 〔0〕 The negative signal is that the underlying reporting problems remain open. The company says its prior audit still carried substantial doubt about its ability to continue as a going concern, while weaknesses involving segregation of duties, review controls, valuation expertise, and U.S. GAAP accounting had not been remediated as of June 30, 2026. 〔1〕 The new auditor may improve oversight, but this filing does not show remediation or improved liquidity. That makes the change more consequential than a routine firm rotation: it puts the company’s financial-reporting infrastructure back in focus without changing the underlying operating story. Bottom line: This is an auditor handoff, not a strategic milestone. The filing modestly worsens the story because unresolved controls and the going-concern warning remain active issues, while offering no evidence they are fixed.

What to watch next

2026 annual audit and updated control assessment

Original filing on SEC EDGAR

More Profusa, Inc. news

Profusa auditor change keeps material weaknesses in focus | PFSA Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.